tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Eric Schmidt, 24 are a BUY (100%).
Analyst Eric Schmidt works at CANTOR FITZGERALD with a stock forecast success ratio of 57.29% fulfilled within 1004.25 days on average.
Eric Schmidt’s has documented 48 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BIIB, Biogen at 20-Feb-2024.
Analyst best performing recommendations are on BIIB (BIOGEN).
The best stock recommendation documented was for BIIB (BIOGEN) at 1/2/2018. The price target of $338 was fulfilled within 1 day with a profit of $3.83 (1.15%) receiving and performance score of 11.46.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
270
$51.08 (23.33%)
270
9 days ago
24/37 (64.86%)
$61.1 (29.25%)
326
Hold
200
$-18.92 (-8.64%)
215
13 days ago
20/23 (86.96%)
$-2.46 (-1.22%)
221
Buy
294
$75.08 (34.30%)
305
14 days ago
7/22 (31.82%)
$92.01 (45.55%)
255
Hold
214
$-4.92 (-2.25%)
250
21 days ago
4/15 (26.67%)
$21.84 (11.37%)
68
Hold
213
$-5.92 (-2.70%)
239
21 days ago
22/24 (91.67%)
$20.84 (10.85%)
139
Which stock is Eric Schmidt is most bullish on?
What Year was the first public recommendation made by Eric Schmidt?
